Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies

Findings among a cohort of 26 patients who had hematologic malignancies and hepatitis E virus (HEV) infection support that HEV can induce chronic hepatitis. However, a 3-month course of ribavirin can induce a rapid viral clearance, reducing the risk for chronic hepatitis and enabling continuation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavitian, Suzanne, Peron, Jean-Marie, Huguet, Françoise, Kamar, Nassim, Abravanel, Florence, Beyne-Rauzy, Odile, Oberic, Lucie, Faguer, Stanislas, Alric, Laurent, Roussel, Murielle, Gaudin, Clément, Ysebaert, Loïc, Huynh, Anne, Recher, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2015
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517705/
https://www.ncbi.nlm.nih.gov/pubmed/26197210
http://dx.doi.org/10.3201/eid2108.150199
_version_ 1782383222118678528
author Tavitian, Suzanne
Peron, Jean-Marie
Huguet, Françoise
Kamar, Nassim
Abravanel, Florence
Beyne-Rauzy, Odile
Oberic, Lucie
Faguer, Stanislas
Alric, Laurent
Roussel, Murielle
Gaudin, Clément
Ysebaert, Loïc
Huynh, Anne
Recher, Christian
author_facet Tavitian, Suzanne
Peron, Jean-Marie
Huguet, Françoise
Kamar, Nassim
Abravanel, Florence
Beyne-Rauzy, Odile
Oberic, Lucie
Faguer, Stanislas
Alric, Laurent
Roussel, Murielle
Gaudin, Clément
Ysebaert, Loïc
Huynh, Anne
Recher, Christian
author_sort Tavitian, Suzanne
collection PubMed
description Findings among a cohort of 26 patients who had hematologic malignancies and hepatitis E virus (HEV) infection support that HEV can induce chronic hepatitis. However, a 3-month course of ribavirin can induce a rapid viral clearance, reducing the risk for chronic hepatitis and enabling continuation of cytotoxic treatments for underlying malignancies.
format Online
Article
Text
id pubmed-4517705
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-45177052015-08-01 Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies Tavitian, Suzanne Peron, Jean-Marie Huguet, Françoise Kamar, Nassim Abravanel, Florence Beyne-Rauzy, Odile Oberic, Lucie Faguer, Stanislas Alric, Laurent Roussel, Murielle Gaudin, Clément Ysebaert, Loïc Huynh, Anne Recher, Christian Emerg Infect Dis Dispatch Findings among a cohort of 26 patients who had hematologic malignancies and hepatitis E virus (HEV) infection support that HEV can induce chronic hepatitis. However, a 3-month course of ribavirin can induce a rapid viral clearance, reducing the risk for chronic hepatitis and enabling continuation of cytotoxic treatments for underlying malignancies. Centers for Disease Control and Prevention 2015-08 /pmc/articles/PMC4517705/ /pubmed/26197210 http://dx.doi.org/10.3201/eid2108.150199 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Tavitian, Suzanne
Peron, Jean-Marie
Huguet, Françoise
Kamar, Nassim
Abravanel, Florence
Beyne-Rauzy, Odile
Oberic, Lucie
Faguer, Stanislas
Alric, Laurent
Roussel, Murielle
Gaudin, Clément
Ysebaert, Loïc
Huynh, Anne
Recher, Christian
Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
title Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
title_full Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
title_fullStr Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
title_full_unstemmed Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
title_short Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
title_sort ribavirin for chronic hepatitis prevention among patients with hematologic malignancies
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517705/
https://www.ncbi.nlm.nih.gov/pubmed/26197210
http://dx.doi.org/10.3201/eid2108.150199
work_keys_str_mv AT tavitiansuzanne ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT peronjeanmarie ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT huguetfrancoise ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT kamarnassim ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT abravanelflorence ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT beynerauzyodile ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT obericlucie ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT faguerstanislas ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT alriclaurent ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT rousselmurielle ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT gaudinclement ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT ysebaertloic ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT huynhanne ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies
AT recherchristian ribavirinforchronichepatitispreventionamongpatientswithhematologicmalignancies

Ejemplares similares